| Website | sanarus.com |
| Category | BioTech |
| Phone | 925-460-6080 |
| Employees | |
| Founded | 1999 |
| Description | invasive devices for diagnosis |
| Series E, 2/07 Easton Capital Alta Partners Forward Ventures Chanel Medical Partners Pequot Capital U.S. Venture Partners | $15M |
Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a line of breast tissue markers that are visible under imaging modalities. The company was founded in 1999 and is headquartered in Pleasanton, California.
